The use of 3D printing in medicine offers considerable potential, particularly in the field of regeneration of human tissue. However, the implementation of these technologies from research into clinical practice is a long process and presents major scientific, technical, regulatory and practical challenges. These include ensuring long-term biocompatibility, achieving functional integration with patient tissue, meeting strict regulatory requirements, and delivering personalised solutions for a wider clinical adoption.
The STRONG-UR project is currently working on an innovative technology to tackle the main clinical challenge, being advanced 3D bioprinting technology combining with patient-specific biomaterials to create personalised tissue. Particularly, it focuses on the treatment of male urethral strictures and on bringing this new methodology to clinical use.
